Health Bulletin 30/September/2022

Here are the top health news for the day:

Delhi: Safdarjung Hospital to ban 3-wheeler

In an order to curb pollution, Safdarjung Hospital is going to ban the entry of three-wheelers on its campus by the end of next month. The hospital will start free-of-cost service by running five battery-operated vehicles to transport passengers from the gate to various centres and OPDs. Doctors and hospital staff will also be allowed to use them to move around the premises.

Can candidates with speech and language benchmark disability seek MBBS admission? SC issues notice to NMC

While considering a plea challenging the 2019 Amendment to Graduate Medical Education Regulations 1997 that barred the candidates with speech and language benchmark disability (quantified at 40% or above) from availing reservation and get admitted to MBBS courses, the Supreme Court on Monday issued notice to the National Medical Commission (NMC).

The counsel for NMC, the Apex medical body has been directed by the top court bench comprising of Justices D.Y. Chandrachud and Hima Kohli to reply in this regard within four weeks.

Filed by an MBBS aspirant who had been denied a seat in a medical college in Karnal due to his speech and language disability. The plea prays before the bench for invoking jurisdiction under Article 142 and allow her to pursue MBBS course in the allocated seat under reserved seats for persons with benchmark disabilities.

For more details, check out the link given below:

Can Candidates With Speech And Language Benchmark Disability Seek MBBS Admission? SC Issues Notice To NMC

Its Final: NEXT will be applicable from 2024, health ministry releases Gazette

Ending all suspense around the applicability of the NExT Exam, the Union Health Ministry has invoked the provisions of the National Medical Commission (NMC) Act by which it has now extended the time limit for conducting the National Exit Test (NExT) till September 2024.

The confirmation of this effect comes from a recent gazette released by the Union Health Ministry imposing an "amendment in NMC Act, 2019 under removal of Difficulty Clause."

Section 15 of the NMC Act provides for the conduct of a common final year undergraduate examination, to be known as the National Exit Test (NExT) which shall be the basis for Registration to practice medicine, admission to PG medical courses and Screening Test for foreign medical graduates to practice modern medicine.

For more details, check out the link given below:

Its Final: NEXT Will Be Applicable From 2024, Health Ministry Releases Gazette

Landmark: Supreme Court upholds same MTP regulations for both married and unmarried women

In a landmark judgment concerning abortion laws in the country, the apex court that is Supreme Court have held that all women, irrespective of their marital status, are entitled to safe and legal abortion till 24 weeks of pregnancy under the Medical Termination of Pregnancy (MTP) Act.

Holding that the rights of reproductive autonomy give similar rights to unmarried women as that to married women the top court bench, in its verdict, said the distinction between married and unmarried women under the abortion laws is "artificial and constitutionally unsustainable" and perpetuates the stereotype that only married women are sexually active.

For more details, check out the link given below:

Landmark: Supreme Court Upholds Same MTP Regulations For Both Married And Unmarried Women

PGI Chandigarh MBBS curriculum sent to Health Ministry for approval, to include modules on Yoga, drug abuse

Implementing its earlier recommendation, the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh has included yoga course in the finalized MBBS academic syllabus.

The finalized syllabus that also includes a course on tobacco/drug abuse and research and innovation for students has already been sent to the Union Ministry of Health and Family Welfare, which shall give the final approval for this.

For more details, check out the link given below:

PGI Chandigarh MBBS Curriculum Sent To Health Ministry For Approval, To Include Modules On Yoga, Drug Abuse

JnJ gets CDSCO panel nod to study antipsychotic drug Paliperidone Palmitate

Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to conduct Phase III clinical trial for antipsychotic Paliperidone Palmitate Prolonged Release Suspension for intramuscular injection 700 mg and 1000 mg, 6 months injection (PP6M) in India.

This came after the drug maker Johnson and Johnson represented comparative efficacy/safety data of PP6M Vs PP3M and PP6M vs PP1M of global clinical trial in global and ethnic Indian (or Indian Origin) patients.

For more details, check out the link given below:

JnJ Gets CDSCO Panel Nod To Study Antipsychotic Drug Paliperidone Palmitate